PTEN公司
磷酸酶
癌变
抑制器
蛋白磷酸酶2
蛋白激酶B
张力素
癌症研究
PI3K/AKT/mTOR通路
双特异性磷酸酶
生物
化学
磷酸化
细胞生物学
生物化学
信号转导
基因
作者
Anne Liu,Yan‐Yu Zhu,Weiping Chen,Glenn Merlino,Yanlin Yu
出处
期刊:Cancers
[Multidisciplinary Digital Publishing Institute]
日期:2022-07-28
卷期号:14 (15): 3666-3666
被引量:11
标识
DOI:10.3390/cancers14153666
摘要
PTEN is the second most highly mutated tumor suppressor in cancer, following only p53. The PTEN protein functions as a phosphatase with lipid- and protein-phosphatase activity. PTEN-lipid-phosphatase activity dephosphorylates PIP3 to form PIP2, and it then antagonizes PI3K and blocks the activation of AKT, while its protein-phosphatase activity dephosphorylates different protein substrates and plays various roles in tumorigenesis. Here, we review the PTEN mutations and protein-phosphatase substrates in tumorigenesis and metastasis. Our purpose is to clarify how PTEN protein phosphatase contributes to its tumor-suppressive functions through PI3K-independent activities.
科研通智能强力驱动
Strongly Powered by AbleSci AI